- $68.66m
- $43.24m
- $0.41m
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Medicinova Announces Mn-001 Abstract Regarding Lipid Metabolism In Nash/Nafld Accepted For Presentation At The Liver Meeting 2021
Brief: Medicinova Announces Mn-166 (Ibudilast) Als Abstract Accepted For Presentation At The 32Nd International Symposium On Als/Mnd
MediciNova Inc reports results for the quarter ended in June - Earnings Summary
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: MediciNova Says Effective July 31, 2021, Edward Stepanow Resigned As CFO
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Iveric Bio, DiDi Global, Advaxis Inc
MediciNova jumps on new U.S. patent for lead drug in neurological eye disorder
Brief: Medicinova Receives Notice Of Allowance For New Patent Covering Mn-166 (Ibudilast) For The Treatment Of Ophthalmic Disease
U.S. STOCKS ON THE MOVE-Energy stocks, travel, leisure stocks, Beyond Meat
U.S. STOCKS ON THE MOVE-Boeing, Toll Brothers, Tesla, Bed Bath & Beyond